Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications

Title:Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications

Volume: 15 Issue: 2

Author(s): Aydin Huseynov, Stefan Baumann, Ibrahim El-Battrawy and Ibrahim Akin

Affiliation:

Keywords: Coumadin, novel oral anticoagulation, thrombembolism, warfarin.

Abstract: The use of novel oral anticoagulation (NOACs) has emerged as an alternative for oral anticoagulation with vitamin-K antagonists in different clinical settings. However, despite the several advantages of these new drugs, there are also several limitations and cautious is recommended in different clinical settings in patients with a high comorbidity index. This review article will describe the current evidence of treatment monitoring, possible drug interaction, and will give an overview about treatment options in case of complications.

Cite this article as:

Huseynov Aydin, Baumann Stefan, El-Battrawy Ibrahim and Akin Ibrahim, Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications, Cardiovascular & Hematological Disorders-Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1871529X1502151209112437